Cetera Investment Advisers
COYA icon

Cetera Investment Advisers’s Coya Therapeutics COYA Stock Holding History

Cetera Investment Advisers’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199K Buy
34,000
+4,000
+13% +$18.5K ﹤0.01% 4496
2026
Q1 		$118K Buy
30,000
+8,000
+36% +$37.4K ﹤0.01% 4412
2025
Q4 		$128K Buy
+22,000
New +$134K ﹤0.01% 4342

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Cetera Investment Advisers's COYA Position: Q2 2026 in Review

Cetera Investment Advisers increased its Coya Therapeutics (COYA) stake by 13% in Q2 2026, buying an estimated $18.5K and bringing the position to 34,000 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #4496.

Cetera Investment Advisers first reported a position in COYA in Q4 2025 and has held it in 3 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Cetera Investment Advisers held 34,000 shares of Coya Therapeutics worth $199K as of Q2 2026.
  • Cetera Investment Advisers bought 4,000 Coya Therapeutics shares in Q2 2026, an estimated $18.5K.
  • Coya Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4496 holding.
  • Cetera Investment Advisers first reported a position in Coya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.